🟢 Arcturus Therapeutics is trading 5.7% up today amid a positive broader-market backdrop

Arcturus Therapeutics is trading 5.7% higher at $13.78, with no fresh company-specific catalyst evident.

• The investor-relations page shows no October 5 announcement; the latest listed release is dated September 23.
• On October 5, the S&P 500 was up 0.59% and the Nasdaq Composite was up 0.96%, indicating a positive market backdrop but not establishing the cause of the stock’s gain.
• No reliable current volume information was found.